WebApr 28, 2024 · Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2024. … WebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are …
Bio-Rad Laboratories, Inc. (BIO) Stock Price Today, Quote & News
Web2 days ago · SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act ... WebApr 10, 2024 · Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 1.7% in the fourth quarter, according to its most recent ... mary holland smith
Sumitomo Mitsui DS Asset Management Company Ltd Has …
WebMar 20, 2024 · BIO Bio-Rad Laboratories, Inc.SEC Filings. BIO. Bio-Rad Laboratories, Inc. 7.89K followers. $466.70 -3.17 ( -0.67%) 3:27 PM 03/20/23. NYSE $USD Realtime. … WebApr 6, 2024 · Bio-Rad Laboratories, Inc. SEC Filing - Quarterly Report (10-Q) October 28, 2024 Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript Bio-Rad Labs … WebApr 13, 2024 · Vaughan Nelson Investment Management L.P. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Rating) by 202.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The firm owned 3,715 shares of the medical research company's stock after … mary hollingsworth author